NEPH
Nephros Inc
NASDAQ: NEPH · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$3.24
-2.41% today
Updated 2026-04-29
Market cap
$34.38M
P/E ratio
29.36
P/S ratio
1.83x
EPS (TTM)
$0.11
Dividend yield
—
52W range
$2 – $6
Volume
0.0M
WallStSmart proprietary scores
41
out of 100
Grade: D
Sell
Investment rating
6.7
Growth
B5.0
Quality
C+5.0
Profitability
C+7.0
Valuation
B+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →204 stocks currently score above 75
Price targets
Analyst target
$7.00
+116.05%
12-Month target
$2.31
-28.70%
Intrinsic (DCF)
$6.68
Margin of safety
+39.52%
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $230000.00 — positive
+ Revenue growth 22.20% QoQ
+ 39.52% below intrinsic value
Risks
No major risks identified
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $9.97M | $14.24M | $14.16M | $18.79M | $18.79M |
| Net income | $-7.38M | $-1.57M | $74000.00 | $1.19M | $62000.00 |
| EPS | — | — | — | — | $0.11 |
| Free cash flow | $-3.37M | $752000.00 | $-547000.00 | $1.65M | $230000.00 |
| Profit margin | -74.01% | -11.06% | 0.52% | 6.35% | 6.36% |
Peer comparison
Smart narrative
Nephros Inc trades at $3.24. representing a P/E of 29.36x trailing earnings. Our Smart Value Score of 41/100 indicates the stock is fair. TTM revenue stands at $18.79M. with profit margins at 6.36%. Our DCF model estimates intrinsic value at $6.68.
Frequently asked questions
What is Nephros Inc's stock price?
Nephros Inc (NEPH) trades at $3.24.
Is Nephros Inc overvalued?
Smart Value Score 41/100 (Grade D, Sell). DCF value $6.68.
What is the price target of Nephros Inc (NEPH)?
The analyst target price is $7.00, representing +116.0% upside from the current price of $3.24.
What is the intrinsic value of Nephros Inc (NEPH)?
Based on our DCF model, intrinsic value is $6.68, a +39.5% margin of safety versus $3.24.
What is Nephros Inc's revenue?
TTM revenue is $18.79M.
Company info
SectorHEALTHCARE
IndustryMEDICAL INSTRUMENTS & SUPPLIES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.83x
ROE12.70%
Beta1.56
50D MA$3.33
200D MA$4.24
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—